Filter Results :

Your search for therapies returned 83 reports

Sort by


Global Allergy Immunotherapies Market 2016-2020

01 Jul 2016  |  Published by:  Technavio-Infiniti Research
About the Allergy Immunotherapies Market Immunotherapy, often referred to as desensitization, is the closest thing to a cure for allergic diseases and is an established treatment for severe allergies such as allergic rhinitis and allergic asthma. Its administration includes increasing the d...

$ 2,500.00

Read More

Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape

01 Jul 2016  |  Published by:  GBI Research
SummaryGBI Research’s latest report, "Stem Cell Therapies - Global Trends in the Competitive, Technological and R&D Landscape" provides an in-depth assessment of the current trends in the global stem cell therapy sector with a particular focus on the technological, competitive an...

$ 2,995.00

Read More

Global Stem Cell Therapies Market Research Report 2016

29 Jun 2016  |  Published by:  9Dimen Research
2016 Global Stem Cell Therapies Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Stem Cell Therapies industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and ...

$ 2,850.00

Read More

Renal Disease Treatments: Products and Therapies

23 Jun 2016  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
The U.S. market for kidney failure treatment will grow from $39.4 billion in 2016 to nearly $45.6 billion by 2021, with a compound annual growth rate (CAGR) of 3.0% for the period of 2016-2021. This report provides: -An in-depth analysis of the market for kidney failure treatment products ...

$ 6,650.00

Read More

Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics

16 Jun 2016  |  Published by:  GBI Research
SummaryUrological cancers are thought to account for 19.5% of global cancer prevalence, with kidney, prostate, testicular and bladder cancer – the key indications covered in this report – accounting for the majority of that figure. Urological cancers affect the male and female urinar...

$ 4,995.00

Read More

Frontier Pharma: Hematological Cancers - Highly Innovative Pipeline Continues Trend towards Targeted, Patient-Specific Therapies

01 Jun 2016  |  Published by:  GBI Research
Summary Hematological malignancies are a class of cancer that affect the blood, lymph nodes and bone marrow, and include numerous forms of leukemia, lymphoma and myeloma. Hematological malignancies constituted 9% of all newly diagnosed malignancies in the US in 2011, with data indicating th...

$ 6,995.00

Read More

Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies

01 Jun 2016  |  Published by:  GBI Research
SummaryDiabetes is a common long-term condition that can lead to a range of disparate and serious complications. It is a lifelong, multi-systemic condition that affects a number of integral organs. Diabetes has a rapidly increasing prevalence – it currently affects 10% of adults globally...

$ 6,995.00

Read More

Obesity Drugs and Therapies: Technologies and Global Markets

18 May 2016  |  Published by:  BCC Research-JT Gabrielsen Consulting LLC Research
The global market for obesity treatments should reach over $7.8 billion by 2021 from over $4.3 billion in 2016 at a compound annual growth rate (CAGR) of 12.7% from 2016 to 2021. This report provides: -An overview of the global markets for obesity drugs, therapies, and related technologi...

$ 6,650.00

Read More

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

01 May 2016  |  Published by:  GBI Research
SummaryNon-Small Cell Lung Cancer (NSCLC) is the most common cancer and cause of cancer-related mortality globally. There were more than 1.8 million newly diagnosed lung cancer cases in 2012 globally, accounting for 13% of the total number of cancer cases. Over half of the incident c...

$ 4,995.00

Read More

Global Cancer Immunotherapies Market 2016-2020

27 Apr 2016  |  Published by:  Technavio-Infiniti Research
About Cancer Immunotherapies Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of ...

$ 2,500.00

Read More

Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market

21 Apr 2016  |  Published by:  GBI Research
SummaryHematological malignancies are a class of cancer that affect the blood, lymph nodes and bone marrow. They include numerous forms of leukemia, lymphoma and myeloma. Hematological malignancies constituted 9% of all newly diagnosed malignancies in the US in 2011, with data indica...

$ 4,995.00

Read More

Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

15 Apr 2016  |  Published by:  GlobalData
SummaryTissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures and markets synthetic proteins. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. It develops vitrogro, which is a synthetic scaffo...

$ 300.00

Read More

Biotie Therapies Corp. (BTH1V) - Financial and Strategic SWOT Analysis Review

15 Apr 2016  |  Published by:  GlobalData
SummaryBiotie Therapies Corp. (Biotie) is a pharmaceutical company that discovers and develops new medicines for the treatment of various diseases. The company offers products for use in the treatment of neurodegenerative and psychiatric disorders such as Parkinson's disease, Alzheimer's disease and...

$ 300.00

Read More

Advanced Catheter Therapies, Inc. - Medical Equipment - Deals and Alliances Profile

07 Apr 2016  |  Published by:  GlobalData
SummaryAdvanced Catheter Therapies, Inc. (ACT) is a medical technology company that provides research and development of medical devices. The company offers product development services which include design, IP patent filing, engineering, working prototyping, bench testing, animal testing, and regul...

$ 250.00

Read More

Targeted Therapies In Asthma: Update Bulletin

01 Apr 2016  |  Published by:  FirstWord
This edition presents key opinion leader (KOL) views on recent developments in the asthma market, including the clinical role of Nucala (mepolizumab; GSK) the prospects for Teva’s recently approved Cinqair (reslizumab) and the future for lebrikizumab (Roche) following the disappointing LAVOLTA...

$ 995.00

Read More
Total 83 records.